Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation
- PMID: 20077161
- PMCID: PMC2954886
- DOI: 10.1007/s12026-009-8134-5
Tyrosine phosphatase SHP-1 in allergic and anaphylactic inflammation
Abstract
Protein tyrosine phosphatase SHP-1 is an essential regulatory molecule in many different signaling pathways. The biological importance of SHP-1 is underscored by the motheaten mutant mouse strains with immunological disorders involving multiple organs and by the close association of aberrant SHP-1 expression with several human diseases. Recent studies provided some compelling evidence that supports a role of SHP-1 in regulating mast cell development and function and also in regulating type 2 allergic inflammatory responses in both innate and adaptive immune responses. In this article, we summarize the recent advancement of our understanding of this interesting phosphatase in the important area of allergic inflammation.
Figures

Similar articles
-
SHP-1 regulation of mast cell function in allergic inflammation and anaphylaxis.PLoS One. 2013;8(2):e55763. doi: 10.1371/journal.pone.0055763. Epub 2013 Feb 4. PLoS One. 2013. PMID: 23390550 Free PMC article.
-
src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.J Clin Invest. 2003 Jan;111(1):109-19. doi: 10.1172/JCI15719. J Clin Invest. 2003. PMID: 12511594 Free PMC article.
-
SHP-1 deficient mast cells are hyperresponsive to stimulation and critical in initiating allergic inflammation in the lung.J Immunol. 2010 Feb 1;184(3):1180-90. doi: 10.4049/jimmunol.0901972. Epub 2009 Dec 30. J Immunol. 2010. PMID: 20042576 Free PMC article.
-
Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.Immunol Res. 2016 Aug;64(4):804-19. doi: 10.1007/s12026-016-8805-y. Immunol Res. 2016. PMID: 27216862 Review.
-
Implication of protein tyrosine phosphatase SHP-1 in cancer-related signaling pathways.Future Oncol. 2016 May;12(10):1287-98. doi: 10.2217/fon-2015-0057. Epub 2016 Mar 18. Future Oncol. 2016. PMID: 26987952 Review.
Cited by
-
SHP1-mediated cell cycle redistribution inhibits radiosensitivity of non-small cell lung cancer.Radiat Oncol. 2013 Jul 10;8:178. doi: 10.1186/1748-717X-8-178. Radiat Oncol. 2013. PMID: 23842094 Free PMC article.
-
Different partners, opposite outcomes: a new perspective of the immunobiology of indoleamine 2,3-dioxygenase.Mol Med. 2012 Jul 18;18(1):834-42. doi: 10.2119/molmed.2012.00029. Mol Med. 2012. PMID: 22481272 Free PMC article. Review.
-
Ets-2 deletion in myeloid cells attenuates IL-1α-mediated inflammatory disease caused by a Ptpn6 point mutation.Cell Mol Immunol. 2021 Jul;18(7):1798-1808. doi: 10.1038/s41423-020-0398-7. Epub 2020 Mar 19. Cell Mol Immunol. 2021. PMID: 32203187 Free PMC article.
-
SHP-1 suppresses the antiviral innate immune response by targeting TRAF3.FASEB J. 2020 Sep;34(9):12392-12405. doi: 10.1096/fj.202000600RR. Epub 2020 Jul 23. FASEB J. 2020. PMID: 32779804 Free PMC article.
-
Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.Signal Transduct Target Ther. 2022 Jun 4;7(1):177. doi: 10.1038/s41392-022-01038-3. Signal Transduct Target Ther. 2022. PMID: 35665742 Free PMC article. Review.
References
-
- Green MC, Shultz LD. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J Hered. 1975;66:250–8. - PubMed
-
- Shultz LD, et al. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 1993;73:1445–54. - PubMed
-
- Tsui HW, Siminovitch KA, de Souza L, Tsui FW. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet. 1993;4:124–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical